cesium N,N-dimethylacetamidocyanooximate | 70791-85-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: cesium N,N-dimethylacetamidocyanooximate
• 英文别名: α-hydroximido-([N,N-dimethylamine]acetamide)acetonitrile；H(DCO)；Acetamide, 2-cyano-2-(hydroxyimino)-N,N-dimethyl-；2-cyano-2-hydroxyimino-N,N-dimethylacetamide
• CAS: 70791-85-4
• 化学式: C₅H₇N₃O₂
• 分子量: 141.129
• InChiKey: FSKSSTQAPZUBLG-UHFFFAOYSA-N

物化性质

• 沸点：
  254.6±23.0 °C(Predicted)
• 密度：
  1.19±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  76.7
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  cesium N,N-dimethylacetamidocyanooximate 在 ammonium hydroxide 、 aluminium amalgam 、 硫化氢 作用下， 生成 N,N-Dimethyl-5-acetamino-thiazol-4-carboxamid
  参考文献：
  名称：

  Azole系列。I. 2-（酰基氨基）硫代乙酰胺的反应，产生5-氨基噻唑和噻唑并[5,4-d]嘧啶。

  摘要：

  研究发现，用乙酸酐加热 2-（酰氨基）硫代乙酰胺很容易生成 5-乙酰胺基取代的噻唑。此外，还介绍了一些 2-（酰氨基）硫代乙酰胺起始物的制备方法，并通过噻唑形成反应获得了 5-乙酰胺基噻唑-4-甲酰胺，从而得到了一些噻唑并[5, 4-d]嘧啶。

  DOI：

  10.1248/cpb.13.1319

文献信息

• Light Insensitive Silver(I) Cyanoximates As Antimicrobial Agents for Indwelling Medical Devices
  作者：Nikolay Gerasimchuk、Andrzej Gamian、Garrett Glover、Bogumila Szponar

  DOI：10.1021/ic100830x

  日期：2010.11.1

  Ten silver(I) cyanoximates of AgL composition (L = NC-C(NO)-R, where R is electron withdrawing groups: -CN, -C(O)NR2, -C(O)R' (alkyl), -C(O)OEt, 2-heteroaryl fragments such as 2-pyridyl, 2-benzimidazolyl, 2-benzoxazolyl, 2-benzthiazolyl) were synthesized and characterized using spectroscopic methods and X-ray analysis. Crystal structures of four complexes were determined and revealed the formation of two-dimensional (2D) coordination polymers of different complexity in which anions exhibit bridging or combined chelate and bridging binding modes. In these compounds, anions are in the nitroso form. All studied AgL complexes are sparingly soluble in water and are thermally stable to 150 degrees C Synthesized compounds demonstrated remarkable insensitivity toward visible light and UV-radiation, which was explained based on their polymeric structures with multiple covalent bonds between bridging cyanoxime ligands and Ag(I) centers. All 10 silver(I) cyanoximates were tested in vitro on the subject of their antimicrobial activity against both Gram-positive and Gram-negative microorganisms such as Escherichia coli, Klebsiella pneumoniae, Proteus sp., Pseudomonas aeruginosa, Enterococcus hirae, Streptococcus mutans, Staphylococcus aureus, and Mycobacterium fortuitum as well as against Candida albicans in solutions, and in the solid state as pressed pellets and dried filter paper disks presoaked with solutions of AgL in DMF. Results showed pronounced antimicrobial activity for all investigated complexes. A combination of five factors: (1) light insensitivity, (2) poor water solubility, (3) high thermal stability, (4) lack of toxicity of organic ligands, and (5) in vitro antimicrobial activity allows development of silver(I) cyanoximates for medical applications. These include antimicrobial additives to acrylate glue, cured by UV-radiation, used in introduction of prosthetic joints and dental implants, and prevention of biofilm formation on several types of indwelling medical devices.
• Domasevich, K. V.; Lindemann, S. V.; Struchkov, Yu. T., Russian Journal of Inorganic Chemistry, <hi>1993</hi>, vol. 38, p. 98 - 103
  作者：Domasevich, K. V.、Lindemann, S. V.、Struchkov, Yu. T.、Gerasimchuk, N. N.、Zhmurko, O. A.

  DOI：——

  日期：——
• Azole Series. I. Reaction of 2-(Acylamino)thioacetamides, leading to 5-Aminothiazoles and to Thiazolo[5, 4-d]pyrimidines.
  作者：Minoru Sekiya、Yoshiro Osaki

  DOI：10.1248/cpb.13.1319

  日期：——

  Formation of 5-acetamido-substituted thiazoles was found to be readily effective on heating 2-(acylamino)thioacetamides with acetic anhydride. In additon, preparation of some starting 2-(acylamino)thioacetamides is described and 5-acetamidothiazole-4-carboxamides obtained by the thiazole formation reaction were led to some thiazolo[5, 4-d]pyrimidines.

  研究发现，用乙酸酐加热 2-（酰氨基）硫代乙酰胺很容易生成 5-乙酰胺基取代的噻唑。此外，还介绍了一些 2-（酰氨基）硫代乙酰胺起始物的制备方法，并通过噻唑形成反应获得了 5-乙酰胺基噻唑-4-甲酰胺，从而得到了一些噻唑并[5, 4-d]嘧啶。